New concepts in anxiety

Abstract

Anxiety and its therapy - today and tomorrow, D.J.Nutt the neuropsychology of anxiety and stress, J.A.Gray et al the neuropharmacology of 5-HT in anxiety, D.G.Grahame-Smith the role of serotonin in anxiety - behavioural approaches, M.Briley et al 5-HT receptor mechanisms in human anxiety, J.F.W.Deakin et al 5-HT receptors in anxiety, J.De Vry et al 5-hydroxytryptamine (5-HT) receptor responsivity in anxiety disorders and depression, K.P.Lesch and M.Osterheider modulations of central serotonergic neurotransmission by chronic ipsapirone in the rat, L.E.Schechter et al anxiogenic and other effects of mCCP, a 5-HT agonist, G.Curzon et al platelet (3H)paroxetine and (3H)imipramine binding in zacopride treated patients with generalized anxiety disorder - preliminary results, J.C.Pecknold et al platelet imipramine binding bmax predicts response to anxiety in alprazolam treated panic disorder patients, J.C.Pecknold et al ondansetron - a novel anti-anxiety agent, F.S.Abuzzahab is receptor heterogeneity relevant to the anxiolytic actions of benzodiazepine receptor ligands?, P.Skolnick central benzodiazepine receptors - quantitative positron emission tomography study in health subjects and anxious patients, P.Abadie et al gaba-independent mechanisms of benzodiazepine action, P.Polc benzodiaxepine dependence, S.E.File and P.K.Hitchcott benzodiazepine withdrawal reactions - distinction from a recurrence of the pretreatment symptons, prevention and treatment, M.B.Sheikman withdrawal symptoms after long-term benzodiazepine dependency and comparison of the abuse potential of two benzodiazepine receptor agonists, S.Apelt et al effects of repeated administration of diazepam to rats on locomotor activity, elevated plus-maze and various brain receptors, M.B.Assie et al comparison of acute and chronic treatment of diazepam and ritanserin in the elevated plus-maze model of anxiety, I.K.Wright et al neurotransmitters in the dorsal periaqueductal grey and animal model of panic anxiety, F.G.Graeff cholecystokinin tetrapeptide - a provocation agent for research in panic disorder?, J.Bradwejn et al the lateral septum as an anxiety-inhibiting structure - a new model for anxiolytic action, E.Yadin and E.Thomas anticonvulsant effect of some anxiolytic drugs on two models of sound-induced seizures in mice, A.Stenger et al anxiogenic effects of scopolamine observed in rats in the elevated plus-maze, U.Falter et al effect of anxiolytic and hyponotic drugs effects on sleep circadian rhythms in the rat, J.Laval et al the implication of noradrenaline in anxiety, A.L.Johnston excitatory amino acids and anxiety, D.N.Stephens et al are glutamatergic pathways involved in the pathophysiology of anxiety?, R.Trullas et al anti-anxiety treatments and human memory, H.V.Curran anxiety and cognition, R.G.Lister cognitive factors in clinical anxiety - potential relevance to therapy, M.W.Eysenck the effects of trait-anxiety on anagram solution times, T.Dalgleish